Drugs / Lpathomab
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02341508 | Sep 2015 → Mar 2016 | — | Lpath, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lpathomab | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02341508 ↗ |
| Route | Intravenous | “Lpathomab Administered Intravenously to Healthy Volunteers” NCT02341508 ↗ |